China’s NMPA approves ILUMETRI (Tildrakizumab Injection) for moderate-to-severe plaque psoriasis treatment
Sun Pharma’s ILUMETRI (Tildrakizumab Injection) receives NMPA approval in China, expanding its market for the treatment of plaque psoriasis.
Category: Pharma News
Read More
World Antimicrobial resistance Awareness Week (WAAW) will replace World Antimicrobial Awareness Week (WAAW)
World Antimicrobial resistance Awareness Week (WAAW) will replace World Antimicrobial Awareness Week (WAAW)
Dr. Reddy’s DRL_TC, a tocilizumab biosimilar, has completed Phase I study (IV route)
In Phase I research, Dr. Reddy’s tocilizumab biosimilar, DRL_TC, demonstrated positive outcomes in safety and efficacy by meeting primary and secondary endpoints.
Darunavir tablets are now available in the US thanks to Lupin
Lupin today announced the release of Darunavir tablets 600 mg and 800 mg as a generic alternative to Janssen Products, LP’s Prezista® Tablets.
Acute Treatment Action Network for urgent, critical, and surgical treatment is announced by World Health Organization
The World Health Organization has introduced the Acute Care Action Network (ACAN), a global coalition of important actors and stakeholders committed to saving millions of lives by advancing action on ECO through stronger action, collectively.
To address the stagnant advancement of the health-related Sustainable Development Goals, immediate action is required: WHO
The WHO unveils 2023 World Health Statistics report with latest COVID-19 impact data and progress towards Sustainable Development Goals
WHO warns against using non-sugar sweeteners for weight control
WHO advises against using non-sugar sweeteners to manage body weight or lower the risk of noncommunicable diseases.
The new WHO report highlights progress and unmet needs for a strong pipeline of antibiotic combating antimicrobial resistance
Although the R&D pipeline for new antibiotics is small and access to both new and existing therapies remains difficult, antimicrobial resistance was linked to approximately 5 million fatalities in 2019.
Thermo and Pfizer partner to offer localized Next-Generation Sequencing (NGS)-based testing for cancer patients worldwide
Thermo Fisher Scientific and Pfizer partner to offer localized next-generation sequencing (NGS)-based testing for cancer patients worldwide
The U.S. introduction of Regadenoson Injection 0.4 mg/5 mL is announced by Dr. Reddy’s Laboratories
Dr. Reddy’s Laboratories Ltd. and its subsidiaries announced the release of Regadenoson injectable, a generic pharmaceutical substitute for Lexiscan® (Regadenoson) injectable that has been given US Food and Drug Administration (USFDA) approval, on the American market.
